Pharmx Technologies Ltd Cash Flow Quality Index
Pharmx Technologies Ltd cash flow quality index. Pharmx Technologies Ltd (PHX) has a Cash Flow Quality Index of 5.80x as of June 2022. Operating cash flow of AU$478.50K exceeds net income of AU$82.50K, indicating high earnings quality where cash backs reported profits. See Pharmx Technologies Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Pharmx Technologies Ltd (2007–2022)
Cash flow quality index of Pharmx Technologies Ltd from 2007 to 2022. Historical Cash Flow Quality Index for Pharmx Technologies Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore PHX operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Pharmx Technologies Ltd Cash Flow Quality Index by Year (2007–2022)
Pharmx Technologies Ltd cash flow quality index by year from 2007 to 2022. Year-by-year earnings quality comparison for Pharmx Technologies Ltd. For the full cash flow conversion analysis, see cash flow conversion of Pharmx Technologies Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 121.83x | AU$2.19 Million | AU$18.00K | ▲ +4103.7% |
| 2021 | 2.90x | AU$3.16 Million | AU$1.09 Million | ▲ +38.2% |
| 2020 | 2.10x | AU$369.00K | AU$176.00K | ▲ +58.5% |
| 2018 | 1.32x | AU$332.00K | AU$251.00K | ▲ +102.8% |
| 2016 | -47.04x | AU$-1.27 Million | AU$27.00K | ▼ -6264.2% |
| 2015 | 0.76x | AU$3.53 Million | AU$4.63 Million | ▼ -42.6% |
| 2014 | 1.33x | AU$5.68 Million | AU$4.27 Million | ▲ +27.7% |
| 2013 | 1.04x | AU$6.61 Million | AU$6.36 Million | ▲ +34.4% |
| 2012 | 0.77x | AU$4.67 Million | AU$6.03 Million | ▼ -63.1% |
| 2011 | 2.10x | AU$3.67 Million | AU$1.75 Million | ▲ +4.6% |
| 2010 | 2.01x | AU$2.26 Million | AU$1.13 Million | ▼ -69.0% |
| 2007 | 6.48x | AU$2.65 Million | AU$409.00K | — |